Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RX
- Prescription Medicines
RISEDRONAT ARENA 5 mg
Bisphosphonate indicated in the treatment and prevention of osteoporosis
Film-coated tablets
5 mg
RISPERIDONA ARENA 1 mg
Atypical antipsychotic drug indicated in the treatment of schizophrenia and behavioural disorders
Film-coated tablets
1 mg
RISPERIDONA ARENA 2 mg
Atypical antipsychotic drug indicated in the treatment of schizophrenia and behavioural disorders
Film-coated tablets
2 mg
RISPERIDONA ARENA 3 mg
Atypical antipsychotic drug indicated in the treatment of schizophrenia and behavioural disorders
Film-coated tablets
3 mg
RISPERIDONA ARENA 4 mg
Atypical antipsychotic drug indicated in the treatment of schizophrenia and behavioural disorders
Film-coated tablets
4 mg
RIVASTIGMINA ARENA 1.5 mg
Cholinesterase inhibitor indicated in the treatment of Alzheimer's type dementia
Capsules
1.5 mg
RIVASTIGMINA ARENA 3 mg
Cholinesterase inhibitor indicated in the treatment of Alzheimer's type dementia
Capsules
3 mg
RIVASTIGMINA ARENA 4.5 mg
Cholinesterase inhibitor indicated in the treatment of Alzheimer's type dementia
Capsules
4.5 mg
RIVASTIGMINA ARENA 6 mg
Cholinesterase inhibitor indicated in the treatment of Alzheimer's type dementia
Capsules
6 mg